Mononuclear and polynuclear complexes of the (1-4, 18-36) NPK, Asp1-Ala-Asp-Ser4-Gly18-
His19-Gly-Gln-Ile-Ser-His24-Lys-Arg-His27-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met36-NH2 …

The effects of tachykinin NK1, NK2 and NK3 receptor agonists and antagonists were
measured on blood pressure (MAP) and heart rate (HR) after bilateral microinjection into the …

Neuropeptide K (NPK), an N-terminally extended form of neurokinin A (NKA), represents the
most potent and longest lasting vasodepressor and cardiomodulatory tachykinin reported …

1 The cardiovascular and behavioural responses to intracerebroventricularly (icv)
administered neuropeptide K (NPK) were studied in conscious rats. The central effects of …

Summary (±) CP-96,345, a nonpeptide and highly selective NK-1 receptor antagonist, was
tested acutely and chronically as an inhibitor of the cardiovascular responses induced by the …

The tachykinins, substance P (SP), neurokinin A (NKA), neuropeptide γ (NP γ) and
neuropeptide K (NPK) are encoded by the single copy preprotachykinin A (PPT-A) gene on …

1 The cardiovascular and behavioural effects elicited by the intracerebroventricular (icv)
administration of neuropeptide γ (NPγ) in the conscious rat were assessed before and 5 min …

In the conscious freely moving rat, the intrathecal (it) injection of neuropeptide K (NPK; 0.65
to 6.5 nmol), at T-9 spinal cord level, produced dose-dependent and prolonged (> 3 h) …

Neuropeptide K (NPK) is a 36-amino acid pepUde which was onginally isolated from
porcine brain extracts [1]. Evidence suggests that NPK is not merely a precursor of …